NCT00683423 - BMS-741672 for Diabetic Neuropathic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions

Neuropathic Pain

Interventions

DRUG

BMS-741672

Tablets, Oral, 100 mg, once daily, 3 weeks

DRUG

Placebo

Tablets, Oral, 0 mg, once daily, 3 weeks treatment period, 2 weeks washout, and 2 weeks follow-up

Trial Locations (8)

Physicians East P.A., Greenville

Palm Beach Neurological Center, Palm Beach Gardens

Comprehensive Neurosciences, Inc., St. Petersburg

Neurology Center Of Ohio, Toledo

The Pain & Rehabilitation Clinic Of Chicago, Chicago

Research Institute Of Dallas, P.A., Dallas

Advanced Biomedical Research Of America, Las Vegas

University Clinical Investigators, Inc., Tustin